Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data

Abstract

These results indicate the effectiveness of agomelatine 25 mg in the treatment of depressed bipolar I patients co-medicated with lithium or valpromide. A randomized controlled trial is planned to confirm these results.